Term
click below
click below
Term
Normal Size Small Size show me how
GBCN Pharm Ch 1
Frandsen, G., & Pennington Abrams' clinical drug therapy: CH 1
Term | Definition |
---|---|
Biotechnology | process that may involve manipulating (DNA) and (RNA) and recombining genes into hybrid molecules that can be inserted into living organisms (often Escherichia coli bacteria) and repeatedly reproduced |
Brand (trade) name | manufacturer’s chosen name for a drug, which is protected by a patent |
Controlled substances | drugs that are categorized by federal law according to therapeutic usefulness and potential for abuse; also known as scheduled drugs |
Drug classifications | groups of medications that are classified according to their effects on particular body systems, their therapeutic uses, and their chemical characteristics |
Generic name | chemical or official name of the drug that is independent of the manufacturer and often indicates the drug group |
Over-the-counter (OTC) drugs | medications available for purchase without a prescription |
Pharmacoeconomics | costs of drug therapy, including costs of purchasing, dispensing, storage, administration, and laboratory and other tests used to monitor patient responses; also considers losses due to expiration |
Pharmacogenomics (pharmacogenetics) | Study of how a person’s genetic heritage leads to variable responses to drugs; more generally refers to genetic polymorphisms that occur in a patient population, such as an ethnic group, as opposed to an individual person |
Pharmacotherapy | use of drugs to prevent, diagnose, or treat signs, symptoms, and disease processes |
Placebo | inert substance containing no medication and given to reinforce a person’s expectation to improve |
Prescription drugs | medications that are ordered in writing by a licensed health care provider |
Prototype | often the first drug of a particular drug class to be developed; usually the standard against which newer, similar drugs are compared |